Growth Flags
show if company had growth for consecutive years
| Sep '22 | Jun '22 | Mar '22 | Dec '21 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.29 | 1.85 | 1.93 | 2.10 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(4.24) | (7.38) | (4.77) | (7.57) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
4.28 | 5.81 | 5.46 | 5.30 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(3.24) | (4.50) | (4.11) | (4.02) | |
EV/FCF |
(3.09) | (4.31) | (3.94) | (3.86) | |
Quick Ratio |
0.10 | 0.93 | 1.23 | 1.36 | |
Current Ratio |
0.14 | 1.17 | 1.52 | 1.58 | |
Net Debt/EBITDA |
(9.50) | (9.77) | (10.70) | (9.47) | |
Debt/Assets |
131.24% | 165.58% | 140.53% | 130.84% | |
Debt/Equity |
(1.09) | (1.77) | (2.09) | (2.22) | |
Asset Turnover |
0.31 | 0.29 | 0.29 | 0.28 | |
Operating CF/Net income |
0.73 | 0.49 | 0.97 | 0.64 | |
Capex/Depreciation |
(0.04) | (0.02) | (0.02) | (0.03) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
100.40% | 113.32% | 123.37% | 116.26% | |
Selling, General and Administrative Expense of Revenue |
99.08% | 101.39% | 85.30% | 92.71% | |
Intangible Assets out of Total Assets |
0.34 | 0.31 | 0.27 | 0.26 | |
Share Based Compensation of Revenue |
15.95% | 16.81% | 19.37% | 19.60% | |
Graham Net Nets |
(3.85) | (2.38) | (2.04) | (1.77) | |
Graham Number |
10.91 | 10.72 | 10.21 | 11.20 | |
Earnings Yield |
(153.78%) | (111.11%) | (104.46%) | (85.24%) | |
Free Cash Flow Yield |
(106.82%) | (73.01%) | (71.97%) | (65.28%) | |
Revenue per Share |
0.21 | 0.22 | 0.25 | 0.31 | |
Operating CF per Share |
(0.28) | (0.24) | (0.42) | (0.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.28) | (0.24) | (0.42) | (0.36) | |
Cash per Share |
0.40 | 0.66 | 0.88 | 1.24 | |
Shareholders Equity per Share |
(2.89) | (2.55) | (2.19) | (2.41) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.89) | (2.55) | (2.19) | (2.41) | |
Free Cash Flow |
(40.70) | (35.17) | (58.56) | (41.41) | |
Working Capital |
(645.66) | 21.01 | 63.70 | 72.87 | |
Capital Expenditures |
(0.09) | (0.05) | (0.06) | (0.07) | |
Net Current Asset Value |
(662.45) | (618.27) | (569.30) | (553.59) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(182.68%) | (221.92%) | (175.69%) | (179.02%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
22.62 | 21.37 | 24.51 | 26.69 | |
Average Payables |
20.97 | 23.35 | 21.42 | 27.00 | |
Average Inventory |
14.35 | 19.11 | 18.34 | 22.20 | |
Average Assets |
427.39 | 482.54 | 500.18 | 539.19 | |
Average Common Equity |
(321.67) | (287.34) | (262.17) | (218.79) |
Columns are period end dates